Cargando…
A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer
SIMPLE SUMMARY: Despite recent developments in immune checkpoint inhibitors, the treatment of locoregionally recurrent head and neck squamous cell cancer (HNSCC) remains challenging. Prospective data comparing re-irradiation with systemic treatment are not available. The SOCCER trial represents a pr...
Autores principales: | Hecht, Markus, Hahn, Dennis, Wolber, Philipp, Hautmann, Matthias G., Reichert, Dietmar, Weniger, Steffi, Belka, Claus, Bergmann, Tobias, Göhler, Thomas, Welslau, Manfred, Große-Thie, Christina, Guntinas-Lichius, Orlando, von der Grün, Jens, Balermpas, Panagiotis, Orlowski, Katrin, Messinger, Diethelm, Stenzel, Karsten G., Fietkau, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305667/ https://www.ncbi.nlm.nih.gov/pubmed/34298628 http://dx.doi.org/10.3390/cancers13143413 |
Ejemplares similares
-
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
por: Hecht, Markus, et al.
Publicado: (2020) -
First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE
por: Le Tourneau, Christophe, et al.
Publicado: (2023) -
Severe skin reaction secondary to concomitant radiotherapy plus cetuximab
por: Berger, Bernhard, et al.
Publicado: (2008) -
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
por: Galbiati, Donata, et al.
Publicado: (2019) -
Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)